Back to mobile site

More on gild

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-435.8% Growth)
- Ratings (8.2 Score)
- Holders
- Dividends (2.4% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/30/26 *Est.)
- M&A (6/30/20 *Est)
- M&A (12/31/20 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GILD Income Statement

Click line-items for a historical chart and %
Product sales 7.41B
Royalty revenues
Contract and other revenues
Total revenues
Cost of goods sold 1.13B
Research and development
Selling, general and administrative 831M
Total costs and expenses 3.1B
Income from operations 4.4B
Interest and other income, net 119M
Interest expense -242M
Income before provision for income taxes 4.28B
Provision for income taxes 951M
Net income 3.33B
Net loss attributable to noncontrolling interest -5M
Net income attributable to Gilead 3.33B
Net income per share attributable to Gilead common stockholders- basic 2.52
Shares used in per share calculation - basic 1.32B
Net income per share attributable to Gilead common stockholders - diluted 2.49
Shares used in per share calculation - diluted 1.34B